Opsenica, Igor M.

Link to this page

Authority KeyName Variants
cb2dcc90-a2ac-473a-b897-4542b8086a76
  • Opsenica, Igor M. (5)

Author's Bibliography

Sinteza novih derivata artemizinina sa antitumorskom aktivnošću na rezistentne ćelije raka

Koračak, Ljiljana K.; Lupšić, Ema; Jovanović, Mirna; Novaković, Miroslav; Pešić, Milica; Opsenica, Igor M.

(Belgrade: Serbian Chemical Society, 2023)

TY  - CONF
AU  - Koračak, Ljiljana K.
AU  - Lupšić, Ema
AU  - Jovanović, Mirna
AU  - Novaković, Miroslav
AU  - Pešić, Milica
AU  - Opsenica, Igor M.
PY  - 2023
UR  - http://radar.ibiss.bg.ac.rs/handle/123456789/6383
AB  - Značaj artemizinina i njegovih derivata se ogleda u biološkoj aktivnosti jer osim što su
našli primjenu kao efikasni lijekovi za liječenje malarije, pokazuju i antitumorsku
aktivnost. Pirimidinsko jezgro je važno zbog prisustva ovog strukturnog motiva u
prirodnim proizvodima, u odobrenim lijekovima, ali i u biološki aktivnim molekulima. U
okviru ovog istraživanja prijavljena je sinteza novih hibridnih molekula dobijenih
povezivanjem dvije farmakofore, kao i njihova antitumorska aktivnost na rezistentnim i
osjetljivim ćelijama nesitnoćelijskog karcinoma pluća.
AB  - In addition to being used for the effective treatment of malaria, artemisinin and derivatives also exhibit anticancer activity. The importance of the pyrimidine scaffold is evidenced by its presence in natural products and approved drugs, as well as in biologically active compounds. In this study, we report the synthesis of novel hybrid molecules comprising two pharmacophores and their activity against sensitive and multidrug‐resistant human non‐small cell lung carcinoma cells.
PB  - Belgrade: Serbian Chemical Society
C3  - Book of Abstracts and Proceedings: 59th meeting of the Serbian Chemical Society; 2023 Jun 1-2; Novi Sad, Serbia
T1  - Sinteza novih derivata artemizinina sa antitumorskom aktivnošću na rezistentne ćelije raka
T1  - Synthesis of novel artemisinin derivatives with anticancer activity against multidrug-resistant cancer cells
SP  - 70
UR  - https://hdl.handle.net/21.15107/rcub_ibiss_6383
ER  - 
@conference{
author = "Koračak, Ljiljana K. and Lupšić, Ema and Jovanović, Mirna and Novaković, Miroslav and Pešić, Milica and Opsenica, Igor M.",
year = "2023",
abstract = "Značaj artemizinina i njegovih derivata se ogleda u biološkoj aktivnosti jer osim što su
našli primjenu kao efikasni lijekovi za liječenje malarije, pokazuju i antitumorsku
aktivnost. Pirimidinsko jezgro je važno zbog prisustva ovog strukturnog motiva u
prirodnim proizvodima, u odobrenim lijekovima, ali i u biološki aktivnim molekulima. U
okviru ovog istraživanja prijavljena je sinteza novih hibridnih molekula dobijenih
povezivanjem dvije farmakofore, kao i njihova antitumorska aktivnost na rezistentnim i
osjetljivim ćelijama nesitnoćelijskog karcinoma pluća., In addition to being used for the effective treatment of malaria, artemisinin and derivatives also exhibit anticancer activity. The importance of the pyrimidine scaffold is evidenced by its presence in natural products and approved drugs, as well as in biologically active compounds. In this study, we report the synthesis of novel hybrid molecules comprising two pharmacophores and their activity against sensitive and multidrug‐resistant human non‐small cell lung carcinoma cells.",
publisher = "Belgrade: Serbian Chemical Society",
journal = "Book of Abstracts and Proceedings: 59th meeting of the Serbian Chemical Society; 2023 Jun 1-2; Novi Sad, Serbia",
title = "Sinteza novih derivata artemizinina sa antitumorskom aktivnošću na rezistentne ćelije raka, Synthesis of novel artemisinin derivatives with anticancer activity against multidrug-resistant cancer cells",
pages = "70",
url = "https://hdl.handle.net/21.15107/rcub_ibiss_6383"
}
Koračak, L. K., Lupšić, E., Jovanović, M., Novaković, M., Pešić, M.,& Opsenica, I. M.. (2023). Sinteza novih derivata artemizinina sa antitumorskom aktivnošću na rezistentne ćelije raka. in Book of Abstracts and Proceedings: 59th meeting of the Serbian Chemical Society; 2023 Jun 1-2; Novi Sad, Serbia
Belgrade: Serbian Chemical Society., 70.
https://hdl.handle.net/21.15107/rcub_ibiss_6383
Koračak LK, Lupšić E, Jovanović M, Novaković M, Pešić M, Opsenica IM. Sinteza novih derivata artemizinina sa antitumorskom aktivnošću na rezistentne ćelije raka. in Book of Abstracts and Proceedings: 59th meeting of the Serbian Chemical Society; 2023 Jun 1-2; Novi Sad, Serbia. 2023;:70.
https://hdl.handle.net/21.15107/rcub_ibiss_6383 .
Koračak, Ljiljana K., Lupšić, Ema, Jovanović, Mirna, Novaković, Miroslav, Pešić, Milica, Opsenica, Igor M., "Sinteza novih derivata artemizinina sa antitumorskom aktivnošću na rezistentne ćelije raka" in Book of Abstracts and Proceedings: 59th meeting of the Serbian Chemical Society; 2023 Jun 1-2; Novi Sad, Serbia (2023):70,
https://hdl.handle.net/21.15107/rcub_ibiss_6383 .

Evading multidrug resistance in glioblastoma with natural compound sclareol and its novel derivatives

Lupšić, Ema; Stepanović, Ana; Stojković, Pavle; Terzić-Jpvanović, Nataša; Novaković, Miroslav; Nedialkov, Paraskev; Trendafilova, Antoaneta; Opsenica, Igor M.; Pešić, Milica

(Belgrade: Serbian Neuroscience Society, 2023)

TY  - CONF
AU  - Lupšić, Ema
AU  - Stepanović, Ana
AU  - Stojković, Pavle
AU  - Terzić-Jpvanović, Nataša
AU  - Novaković, Miroslav
AU  - Nedialkov, Paraskev
AU  - Trendafilova, Antoaneta
AU  - Opsenica, Igor M.
AU  - Pešić, Milica
PY  - 2023
UR  - http://radar.ibiss.bg.ac.rs/handle/123456789/5928
AB  - Background: Glioblastoma is a highly aggressive and resistant brain tumor. P-glycoprotein
(P-gp) constitutes the blood-brain barrier and is expressed on the cell membrane of multidrugresistant (MDR) glioblastoma cells. Our objective was to investigate the anti-glioblastoma
effects of sclareol (SCL), a natural diterpene alcohol, and its two derivatives (11c and 12l).
Methods: Our cellular model included human glioblastoma U87 cell line without P-gp
expression, its MDR counterpart U87-TxR with P-gp expression, and normal lung fibroblasts
MRC-5. Cytotoxic effects were examined by MTT. P-gp function, cell cycle disturbance,
time-dependent cell death induction, the level of reactive oxygen and nitrogen species, and
changes in the mitochondrial membrane potential were studied by flow cytometry. Results:
SCL and its derivatives evaded the MDR in glioblastoma cells, showing lower IC50 values in
U87-TxR than in U87, referred to as collateral sensitivity. Both derivatives were more potent
than SCL, while 12l was active in the nanomolar range. 11c and 12l displayed greater
selectivity towards glioblastoma cells compared to SCL. All compounds significantly
disturbed the cell cycle and induced cell death: SCL - late apoptosis and necrosis, 11c - only
early apoptosis, and 12l - early and late apoptosis. SCL and its derivatives acted as
antioxidants, while 11c and 12l decreased mitochondrial membrane potential. Conclusion:
SCL derivatives were more potent than SCL. The observed collateral sensitivity in
glioblastoma cells can be explained by oxidative stress modulation because although resistant
due to P-gp expression, U87-TxR cells are more susceptible to changes in oxidative status
than U87 cells.
PB  - Belgrade: Serbian Neuroscience Society
C3  - Book of abstracts: 8th Congress of Serbian neuroscience society with international participation; 2023 May 31 - Jun 2; Belgrade, Serbia
T1  - Evading multidrug resistance in glioblastoma with natural compound sclareol and its novel derivatives
SP  - 72
UR  - https://hdl.handle.net/21.15107/rcub_ibiss_5928
ER  - 
@conference{
author = "Lupšić, Ema and Stepanović, Ana and Stojković, Pavle and Terzić-Jpvanović, Nataša and Novaković, Miroslav and Nedialkov, Paraskev and Trendafilova, Antoaneta and Opsenica, Igor M. and Pešić, Milica",
year = "2023",
abstract = "Background: Glioblastoma is a highly aggressive and resistant brain tumor. P-glycoprotein
(P-gp) constitutes the blood-brain barrier and is expressed on the cell membrane of multidrugresistant (MDR) glioblastoma cells. Our objective was to investigate the anti-glioblastoma
effects of sclareol (SCL), a natural diterpene alcohol, and its two derivatives (11c and 12l).
Methods: Our cellular model included human glioblastoma U87 cell line without P-gp
expression, its MDR counterpart U87-TxR with P-gp expression, and normal lung fibroblasts
MRC-5. Cytotoxic effects were examined by MTT. P-gp function, cell cycle disturbance,
time-dependent cell death induction, the level of reactive oxygen and nitrogen species, and
changes in the mitochondrial membrane potential were studied by flow cytometry. Results:
SCL and its derivatives evaded the MDR in glioblastoma cells, showing lower IC50 values in
U87-TxR than in U87, referred to as collateral sensitivity. Both derivatives were more potent
than SCL, while 12l was active in the nanomolar range. 11c and 12l displayed greater
selectivity towards glioblastoma cells compared to SCL. All compounds significantly
disturbed the cell cycle and induced cell death: SCL - late apoptosis and necrosis, 11c - only
early apoptosis, and 12l - early and late apoptosis. SCL and its derivatives acted as
antioxidants, while 11c and 12l decreased mitochondrial membrane potential. Conclusion:
SCL derivatives were more potent than SCL. The observed collateral sensitivity in
glioblastoma cells can be explained by oxidative stress modulation because although resistant
due to P-gp expression, U87-TxR cells are more susceptible to changes in oxidative status
than U87 cells.",
publisher = "Belgrade: Serbian Neuroscience Society",
journal = "Book of abstracts: 8th Congress of Serbian neuroscience society with international participation; 2023 May 31 - Jun 2; Belgrade, Serbia",
title = "Evading multidrug resistance in glioblastoma with natural compound sclareol and its novel derivatives",
pages = "72",
url = "https://hdl.handle.net/21.15107/rcub_ibiss_5928"
}
Lupšić, E., Stepanović, A., Stojković, P., Terzić-Jpvanović, N., Novaković, M., Nedialkov, P., Trendafilova, A., Opsenica, I. M.,& Pešić, M.. (2023). Evading multidrug resistance in glioblastoma with natural compound sclareol and its novel derivatives. in Book of abstracts: 8th Congress of Serbian neuroscience society with international participation; 2023 May 31 - Jun 2; Belgrade, Serbia
Belgrade: Serbian Neuroscience Society., 72.
https://hdl.handle.net/21.15107/rcub_ibiss_5928
Lupšić E, Stepanović A, Stojković P, Terzić-Jpvanović N, Novaković M, Nedialkov P, Trendafilova A, Opsenica IM, Pešić M. Evading multidrug resistance in glioblastoma with natural compound sclareol and its novel derivatives. in Book of abstracts: 8th Congress of Serbian neuroscience society with international participation; 2023 May 31 - Jun 2; Belgrade, Serbia. 2023;:72.
https://hdl.handle.net/21.15107/rcub_ibiss_5928 .
Lupšić, Ema, Stepanović, Ana, Stojković, Pavle, Terzić-Jpvanović, Nataša, Novaković, Miroslav, Nedialkov, Paraskev, Trendafilova, Antoaneta, Opsenica, Igor M., Pešić, Milica, "Evading multidrug resistance in glioblastoma with natural compound sclareol and its novel derivatives" in Book of abstracts: 8th Congress of Serbian neuroscience society with international participation; 2023 May 31 - Jun 2; Belgrade, Serbia (2023):72,
https://hdl.handle.net/21.15107/rcub_ibiss_5928 .

Sinteza i citotoksičnost novih derivata sklareola

Stojković, Pavle A.; Stepanović, Ana; Lupšić, Ema; Terzić Jovanović, Nataša; Novaković, Miroslav; Pešić, Milica; Opsenica, Igor M.

(Belgrade: Serbian Chemical Society, 2023)

TY  - CONF
AU  - Stojković, Pavle A.
AU  - Stepanović, Ana
AU  - Lupšić, Ema
AU  - Terzić Jovanović, Nataša
AU  - Novaković, Miroslav
AU  - Pešić, Milica
AU  - Opsenica, Igor M.
PY  - 2023
UR  - http://radar.ibiss.bg.ac.rs/handle/123456789/5911
AB  - Sklareol, biološki aktivan diterpen, je iskorišćen kao polazna supstanca za sintezu novih hibridnih molekula sa 1,2,4-triazolo[1,5-a]-pirimidinskim jezgrom (Slika 1). Svi derivati sklareola su testirani na ćelijsku liniju ljudskog glioblastoma U 7 i ćelijsku liniju U 7-TxR koja ispoljava višestruku rezistenciju na lekove. Jedinjenja su modifikovala aktivnost P-glikoproteina u sličnoj meri kao P-gp inhibitor treće generacije – tarikvidar. Ispitan je uticaj novih jedinjenja na različite ćelijske procese među kojima su ćelijski ciklus i ćelijska smrt, kao i na koncentraciju reaktivnih kiseoničnih i azotnih vrsta (ROS/RNS) u ćelijama glioblastoma i na potencijal membrane mitohondrija.
AB  - Sclareol, a biologically active diterpenoid, was used as the starting material for the synthesis of novel hybrid molecules containing the 1,2,4-triazolo[1,5-a]-pyrimidine moiety. All sclareol derivatives were tested on human glioblastoma U87 and multi-drug resistant U87-TxR cells. Hybrid compounds decreased P-gp activity to the same extent as a third generation P-gp inhibitor - tariquidar. We examined the effect of novel compounds on various cellular processes including the cell cycle and cell death, as well as their influence on the levels of reactive oxygen and nitrogen species (ROS/RNS) and mitochondrial membrane potential in glioblastoma cells.
PB  - Belgrade: Serbian Chemical Society
C3  - Book of Abstracts and Proceedings: 59th meeting of the Serbian Chemical Society; 2023 Jun 1-2; Novi Sad, Serbia
T1  - Sinteza i citotoksičnost novih derivata sklareola
T1  - Synthesis and cytotoxic activity of novel sclareol derivatives
SP  - 77
UR  - https://hdl.handle.net/21.15107/rcub_ibiss_5911
ER  - 
@conference{
author = "Stojković, Pavle A. and Stepanović, Ana and Lupšić, Ema and Terzić Jovanović, Nataša and Novaković, Miroslav and Pešić, Milica and Opsenica, Igor M.",
year = "2023",
abstract = "Sklareol, biološki aktivan diterpen, je iskorišćen kao polazna supstanca za sintezu novih hibridnih molekula sa 1,2,4-triazolo[1,5-a]-pirimidinskim jezgrom (Slika 1). Svi derivati sklareola su testirani na ćelijsku liniju ljudskog glioblastoma U 7 i ćelijsku liniju U 7-TxR koja ispoljava višestruku rezistenciju na lekove. Jedinjenja su modifikovala aktivnost P-glikoproteina u sličnoj meri kao P-gp inhibitor treće generacije – tarikvidar. Ispitan je uticaj novih jedinjenja na različite ćelijske procese među kojima su ćelijski ciklus i ćelijska smrt, kao i na koncentraciju reaktivnih kiseoničnih i azotnih vrsta (ROS/RNS) u ćelijama glioblastoma i na potencijal membrane mitohondrija., Sclareol, a biologically active diterpenoid, was used as the starting material for the synthesis of novel hybrid molecules containing the 1,2,4-triazolo[1,5-a]-pyrimidine moiety. All sclareol derivatives were tested on human glioblastoma U87 and multi-drug resistant U87-TxR cells. Hybrid compounds decreased P-gp activity to the same extent as a third generation P-gp inhibitor - tariquidar. We examined the effect of novel compounds on various cellular processes including the cell cycle and cell death, as well as their influence on the levels of reactive oxygen and nitrogen species (ROS/RNS) and mitochondrial membrane potential in glioblastoma cells.",
publisher = "Belgrade: Serbian Chemical Society",
journal = "Book of Abstracts and Proceedings: 59th meeting of the Serbian Chemical Society; 2023 Jun 1-2; Novi Sad, Serbia",
title = "Sinteza i citotoksičnost novih derivata sklareola, Synthesis and cytotoxic activity of novel sclareol derivatives",
pages = "77",
url = "https://hdl.handle.net/21.15107/rcub_ibiss_5911"
}
Stojković, P. A., Stepanović, A., Lupšić, E., Terzić Jovanović, N., Novaković, M., Pešić, M.,& Opsenica, I. M.. (2023). Sinteza i citotoksičnost novih derivata sklareola. in Book of Abstracts and Proceedings: 59th meeting of the Serbian Chemical Society; 2023 Jun 1-2; Novi Sad, Serbia
Belgrade: Serbian Chemical Society., 77.
https://hdl.handle.net/21.15107/rcub_ibiss_5911
Stojković PA, Stepanović A, Lupšić E, Terzić Jovanović N, Novaković M, Pešić M, Opsenica IM. Sinteza i citotoksičnost novih derivata sklareola. in Book of Abstracts and Proceedings: 59th meeting of the Serbian Chemical Society; 2023 Jun 1-2; Novi Sad, Serbia. 2023;:77.
https://hdl.handle.net/21.15107/rcub_ibiss_5911 .
Stojković, Pavle A., Stepanović, Ana, Lupšić, Ema, Terzić Jovanović, Nataša, Novaković, Miroslav, Pešić, Milica, Opsenica, Igor M., "Sinteza i citotoksičnost novih derivata sklareola" in Book of Abstracts and Proceedings: 59th meeting of the Serbian Chemical Society; 2023 Jun 1-2; Novi Sad, Serbia (2023):77,
https://hdl.handle.net/21.15107/rcub_ibiss_5911 .

Novel hybrids of sclareol and 1,2,4-triazolo[1,5-a]pyrimidine show collateral sensitivity in multidrug-resistant glioblastoma cells

Stojković, Pavle; Stepanović, Ana; Lupšić, Ema; Terzić Jovanović, Nataša; Novaković, Miroslav; Nedialkov, Paraskev; Trendafilova, Antoaneta; Pešić, Milica; Opsenica, Igor M.

(Academic Press Inc., 2023)

TY  - JOUR
AU  - Stojković, Pavle
AU  - Stepanović, Ana
AU  - Lupšić, Ema
AU  - Terzić Jovanović, Nataša
AU  - Novaković, Miroslav
AU  - Nedialkov, Paraskev
AU  - Trendafilova, Antoaneta
AU  - Pešić, Milica
AU  - Opsenica, Igor M.
PY  - 2023
UR  - http://radar.ibiss.bg.ac.rs/handle/123456789/5910
AB  - The synthesis of 24 hybrid molecules, consisting of naturally occurring sclareol (SCL) and synthetic 1,2,4-triazolo
[1,5-a]pyrimidines (TPs), is described. New compounds were designed with the aim of improving the cytotoxic
properties, activity, and selectivity of the parent compounds. Six analogs (12a-f) contained 4-benzylpiperazine
linkage, while 4-benzyldiamine linkage was present in eighteen derivatives (12g-r and 13a-f). Hybrids 13a-f
consist of two TP units. After purification, all hybrids (12a-r and 13a-f), as well as their precursors (9a-e and
11a-c), were tested on human glioblastoma U87 cells. More than half of the tested synthesized molecules, 16 out
of 31, caused a significant reduction of U87 cell viability (more than 75% reduction) at 30 μM. The
concentration-dependent cytotoxicity of these 16 compounds was also examined on U87 cells, corresponding
multidrug-resistant (MDR) U87-TxR cells with increased P-glycoprotein (P-gp) expression and activity, and
normal lung fibroblasts MRC-5. Importantly, 12l and 12r were active in the nanomolar range, while seven
compounds (11b, 11c, 12i, 12l, 12n, 12q, and 12r) were more selective towards glioblastoma cells than SCL. All
compounds except 12r evaded MDR, showing even better cytotoxicity in U87-TxR cells. In particular, 11c, 12a,
12g, 12j, 12k, 12m, 12n, and SCL showed collateral sensitivity. Hybrid compounds 12l, 12q, and 12r decreased
P-gp activity to the same extent as a well-known P-gp inhibitor - tariquidar (TQ). Hybrid compound 12l and its
precursor 11c affected different cellular processes including the cell cycle, cell death, and mitochondrial
membrane potential, and changed the levels of reactive oxygen and nitrogen species (ROS/RNS) in glioblastoma
cells. Collateral sensitivity towards MDR glioblastoma cells was caused by the modulation of oxidative stress
accompanied by inhibition of mitochondria.
PB  - Academic Press Inc.
T2  - Bioorganic Chemistry
T1  - Novel hybrids of sclareol and 1,2,4-triazolo[1,5-a]pyrimidine show collateral sensitivity in multidrug-resistant glioblastoma cells
VL  - 138
DO  - 10.1016/j.bioorg.2023.106605
SP  - 106605
ER  - 
@article{
author = "Stojković, Pavle and Stepanović, Ana and Lupšić, Ema and Terzić Jovanović, Nataša and Novaković, Miroslav and Nedialkov, Paraskev and Trendafilova, Antoaneta and Pešić, Milica and Opsenica, Igor M.",
year = "2023",
abstract = "The synthesis of 24 hybrid molecules, consisting of naturally occurring sclareol (SCL) and synthetic 1,2,4-triazolo
[1,5-a]pyrimidines (TPs), is described. New compounds were designed with the aim of improving the cytotoxic
properties, activity, and selectivity of the parent compounds. Six analogs (12a-f) contained 4-benzylpiperazine
linkage, while 4-benzyldiamine linkage was present in eighteen derivatives (12g-r and 13a-f). Hybrids 13a-f
consist of two TP units. After purification, all hybrids (12a-r and 13a-f), as well as their precursors (9a-e and
11a-c), were tested on human glioblastoma U87 cells. More than half of the tested synthesized molecules, 16 out
of 31, caused a significant reduction of U87 cell viability (more than 75% reduction) at 30 μM. The
concentration-dependent cytotoxicity of these 16 compounds was also examined on U87 cells, corresponding
multidrug-resistant (MDR) U87-TxR cells with increased P-glycoprotein (P-gp) expression and activity, and
normal lung fibroblasts MRC-5. Importantly, 12l and 12r were active in the nanomolar range, while seven
compounds (11b, 11c, 12i, 12l, 12n, 12q, and 12r) were more selective towards glioblastoma cells than SCL. All
compounds except 12r evaded MDR, showing even better cytotoxicity in U87-TxR cells. In particular, 11c, 12a,
12g, 12j, 12k, 12m, 12n, and SCL showed collateral sensitivity. Hybrid compounds 12l, 12q, and 12r decreased
P-gp activity to the same extent as a well-known P-gp inhibitor - tariquidar (TQ). Hybrid compound 12l and its
precursor 11c affected different cellular processes including the cell cycle, cell death, and mitochondrial
membrane potential, and changed the levels of reactive oxygen and nitrogen species (ROS/RNS) in glioblastoma
cells. Collateral sensitivity towards MDR glioblastoma cells was caused by the modulation of oxidative stress
accompanied by inhibition of mitochondria.",
publisher = "Academic Press Inc.",
journal = "Bioorganic Chemistry",
title = "Novel hybrids of sclareol and 1,2,4-triazolo[1,5-a]pyrimidine show collateral sensitivity in multidrug-resistant glioblastoma cells",
volume = "138",
doi = "10.1016/j.bioorg.2023.106605",
pages = "106605"
}
Stojković, P., Stepanović, A., Lupšić, E., Terzić Jovanović, N., Novaković, M., Nedialkov, P., Trendafilova, A., Pešić, M.,& Opsenica, I. M.. (2023). Novel hybrids of sclareol and 1,2,4-triazolo[1,5-a]pyrimidine show collateral sensitivity in multidrug-resistant glioblastoma cells. in Bioorganic Chemistry
Academic Press Inc.., 138, 106605.
https://doi.org/10.1016/j.bioorg.2023.106605
Stojković P, Stepanović A, Lupšić E, Terzić Jovanović N, Novaković M, Nedialkov P, Trendafilova A, Pešić M, Opsenica IM. Novel hybrids of sclareol and 1,2,4-triazolo[1,5-a]pyrimidine show collateral sensitivity in multidrug-resistant glioblastoma cells. in Bioorganic Chemistry. 2023;138:106605.
doi:10.1016/j.bioorg.2023.106605 .
Stojković, Pavle, Stepanović, Ana, Lupšić, Ema, Terzić Jovanović, Nataša, Novaković, Miroslav, Nedialkov, Paraskev, Trendafilova, Antoaneta, Pešić, Milica, Opsenica, Igor M., "Novel hybrids of sclareol and 1,2,4-triazolo[1,5-a]pyrimidine show collateral sensitivity in multidrug-resistant glioblastoma cells" in Bioorganic Chemistry, 138 (2023):106605,
https://doi.org/10.1016/j.bioorg.2023.106605 . .
3
1
1

Sclareol, a fragrant natural compound, suppresses P-glycoprotein activity and sensitizes resistant cancer cells to doxorubicin

Lupšić, Ema; Stepanović, Ana; Nikolić, Andrea M.; Dragoj, Miodrag; Jovanović Stojanov, Sofija; Novaković, Miroslav; Opsenica, Igor M.; Pešić, Milica

(STRATAGEM, 2021)

TY  - CONF
AU  - Lupšić, Ema
AU  - Stepanović, Ana
AU  - Nikolić, Andrea M.
AU  - Dragoj, Miodrag
AU  - Jovanović Stojanov, Sofija
AU  - Novaković, Miroslav
AU  - Opsenica, Igor M.
AU  - Pešić, Milica
PY  - 2021
UR  - https://stratagem-cost.eu/2021/09/stratagems-4th-annual-conference-in-prague-czechia-to-take-place-on/
UR  - http://radar.ibiss.bg.ac.rs/handle/123456789/5957
AB  - Multidrug resistance (MDR) is one of the major obstacles to successful cancer treatment. How to
overcome cancer MDR is still an unsolved issue in clinical practice although several generations of MDR
transporters’ inhibitors have been developed and widely investigated so far. Nature is an important source
of potential anticancer agents capable to suppress the activity of membrane transporters implicated in MDR
such as P-glycoprotein (P-gp). In this study, we evaluated the effects of sclareol (SC), a naturally occurring
labdane type diterpene, on the P-gp activity and its potential to sensitize different human cancer cell lines
to doxorubicin (DOX). To that end, we used several human cancer cell lines (colorectal carcinoma, DLD1,
and its MDR variant DLD1-TxR, non-small cell lung carcinoma NCI-H460, and its MDR variant NCIH460/R, glioblastoma U251, U87, and its MDR variant U87-TxR) and normal human embryonic lung fibroblasts (MRC-5). The effects of SC alone and in combination with DOX on cell viability were assessed by
MTT, while the effects on DOX and rhodamine 123 (Rho 123) accumulation as determinants of P-gp activity
were assessed by flow cytometry. The efficient concentrations of SC that significantly decreased cell viability
(IC50 values) ranged between 20 µM for DLD1 and 60 µM for MRC-5. The presence of MDR phenotype did
not diminish the SC effect on cell viability, even more, SC was more potent in U87-TxR than in U87 cells.
The effects of 72 h simultaneous treatment of SC (10 and 20 µM) with DOX (20, 50, 100, 200 and 500 nM)
demonstrated the considerable potential of SC to sensitize DLD1, DLD1-TxR, NCI-H460/R, U87-TxR and
U251 cells to DOX. However, the observed sensitization was not due to the P-gp inhibition in all MDR cancer
cell lines. Only in NCI-H460/R the obvious suppression of P-gp was observed due to the significant increase
in the accumulation of both P-gp substrates (DOX and Rho 123). SC did not affect the P-gp activity in DLD1
and DLD1-TxR cells. On the contrary, DOX and Rho123 accumulation increased in U87 and U87-TxR albeit
the fact that U87 cells do not express P-gp. Results obtained in this study showed a considerable potential
of SC to sensitize cancer cells to DOX. However, the effects of SC are cancer type-specific and not solely
dependent on the suppression of P-gp activity. Further investigations are envisioned to determine molecular
mechanisms of SC in different cancer cell types.
PB  - STRATAGEM
C3  - 4th Annual STRATAGEM Conference: New Diagnostic and therapeutic tools against multidrug resistant tumours; 2021 Sep 6-8; Prague; Czechia
T1  - Sclareol, a fragrant natural compound, suppresses P-glycoprotein activity and sensitizes resistant cancer cells to doxorubicin
UR  - https://hdl.handle.net/21.15107/rcub_ibiss_5957
ER  - 
@conference{
author = "Lupšić, Ema and Stepanović, Ana and Nikolić, Andrea M. and Dragoj, Miodrag and Jovanović Stojanov, Sofija and Novaković, Miroslav and Opsenica, Igor M. and Pešić, Milica",
year = "2021",
abstract = "Multidrug resistance (MDR) is one of the major obstacles to successful cancer treatment. How to
overcome cancer MDR is still an unsolved issue in clinical practice although several generations of MDR
transporters’ inhibitors have been developed and widely investigated so far. Nature is an important source
of potential anticancer agents capable to suppress the activity of membrane transporters implicated in MDR
such as P-glycoprotein (P-gp). In this study, we evaluated the effects of sclareol (SC), a naturally occurring
labdane type diterpene, on the P-gp activity and its potential to sensitize different human cancer cell lines
to doxorubicin (DOX). To that end, we used several human cancer cell lines (colorectal carcinoma, DLD1,
and its MDR variant DLD1-TxR, non-small cell lung carcinoma NCI-H460, and its MDR variant NCIH460/R, glioblastoma U251, U87, and its MDR variant U87-TxR) and normal human embryonic lung fibroblasts (MRC-5). The effects of SC alone and in combination with DOX on cell viability were assessed by
MTT, while the effects on DOX and rhodamine 123 (Rho 123) accumulation as determinants of P-gp activity
were assessed by flow cytometry. The efficient concentrations of SC that significantly decreased cell viability
(IC50 values) ranged between 20 µM for DLD1 and 60 µM for MRC-5. The presence of MDR phenotype did
not diminish the SC effect on cell viability, even more, SC was more potent in U87-TxR than in U87 cells.
The effects of 72 h simultaneous treatment of SC (10 and 20 µM) with DOX (20, 50, 100, 200 and 500 nM)
demonstrated the considerable potential of SC to sensitize DLD1, DLD1-TxR, NCI-H460/R, U87-TxR and
U251 cells to DOX. However, the observed sensitization was not due to the P-gp inhibition in all MDR cancer
cell lines. Only in NCI-H460/R the obvious suppression of P-gp was observed due to the significant increase
in the accumulation of both P-gp substrates (DOX and Rho 123). SC did not affect the P-gp activity in DLD1
and DLD1-TxR cells. On the contrary, DOX and Rho123 accumulation increased in U87 and U87-TxR albeit
the fact that U87 cells do not express P-gp. Results obtained in this study showed a considerable potential
of SC to sensitize cancer cells to DOX. However, the effects of SC are cancer type-specific and not solely
dependent on the suppression of P-gp activity. Further investigations are envisioned to determine molecular
mechanisms of SC in different cancer cell types.",
publisher = "STRATAGEM",
journal = "4th Annual STRATAGEM Conference: New Diagnostic and therapeutic tools against multidrug resistant tumours; 2021 Sep 6-8; Prague; Czechia",
title = "Sclareol, a fragrant natural compound, suppresses P-glycoprotein activity and sensitizes resistant cancer cells to doxorubicin",
url = "https://hdl.handle.net/21.15107/rcub_ibiss_5957"
}
Lupšić, E., Stepanović, A., Nikolić, A. M., Dragoj, M., Jovanović Stojanov, S., Novaković, M., Opsenica, I. M.,& Pešić, M.. (2021). Sclareol, a fragrant natural compound, suppresses P-glycoprotein activity and sensitizes resistant cancer cells to doxorubicin. in 4th Annual STRATAGEM Conference: New Diagnostic and therapeutic tools against multidrug resistant tumours; 2021 Sep 6-8; Prague; Czechia
STRATAGEM..
https://hdl.handle.net/21.15107/rcub_ibiss_5957
Lupšić E, Stepanović A, Nikolić AM, Dragoj M, Jovanović Stojanov S, Novaković M, Opsenica IM, Pešić M. Sclareol, a fragrant natural compound, suppresses P-glycoprotein activity and sensitizes resistant cancer cells to doxorubicin. in 4th Annual STRATAGEM Conference: New Diagnostic and therapeutic tools against multidrug resistant tumours; 2021 Sep 6-8; Prague; Czechia. 2021;.
https://hdl.handle.net/21.15107/rcub_ibiss_5957 .
Lupšić, Ema, Stepanović, Ana, Nikolić, Andrea M., Dragoj, Miodrag, Jovanović Stojanov, Sofija, Novaković, Miroslav, Opsenica, Igor M., Pešić, Milica, "Sclareol, a fragrant natural compound, suppresses P-glycoprotein activity and sensitizes resistant cancer cells to doxorubicin" in 4th Annual STRATAGEM Conference: New Diagnostic and therapeutic tools against multidrug resistant tumours; 2021 Sep 6-8; Prague; Czechia (2021),
https://hdl.handle.net/21.15107/rcub_ibiss_5957 .